These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 9232846

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Theoretical conformational analysis of three vasopressin antagonists with a modified cyclohexyl ring in the first thioacid residue.
    Kaźmierkiewicz R, Liwo A, Lammek B.
    Int J Pept Protein Res; 1995 May; 45(5):451-8. PubMed ID: 7591484
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and some pharmacological properties of oxytocin and vasopressin analogues with sarcosine or N-methyl-L-alanine in position 7.
    Grzonka Z, Lammek B, Kasprzykowski F, Gazis D, Schwartz IL.
    J Med Chem; 1983 Apr; 26(4):555-9. PubMed ID: 6187921
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Potent antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid),2-D- phenylalanine,4-valine]arginine-vasopressin at position 4.
    Manning M, Olma A, Klis WA, Seto J, Sawyer WH.
    J Med Chem; 1983 Nov; 26(11):1607-13. PubMed ID: 6631916
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Position three in vasopressin antagonist tolerates conformationally restricted and aromatic amino acid substitutions: a striking contrast with vasopressin agonists.
    Manning M, Cheng LL, Stoev S, Klis W, Nawrocka E, Olma A, Sawyer WH, Wo NC, Chan WY.
    J Pept Sci; 1997 Nov; 3(1):31-46. PubMed ID: 9230469
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synthesis and biological activities of arginine-vasopressin analogues with 4-hydroxyproline in position 7.
    Buku A, Schwartz IL, Yamin N, Wyssbrod HR, Gazis D.
    J Med Chem; 1987 Aug; 30(8):1509-12. PubMed ID: 3612693
    [Abstract] [Full Text] [Related]

  • 15. Influence of sarcosine or N-methylalanine in position 7 on the antagonistic properties of [1-deaminopenicillamine]- and [1-(beta-mercapto-beta, beta-cyclopentylmethylene-propionic acid)]-vasopressin.
    Gazis D, Schwartz IL, Lammek B, Grzonka Z.
    Int J Pept Protein Res; 1984 Jan; 23(1):78-83. PubMed ID: 6199318
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Solution structure of conformationally restricted vasopressin analogues.
    Trzepałka E, Oleszczuk M, Maciejczyk M, Lammek B.
    Acta Biochim Pol; 2004 Jan; 51(1):33-49. PubMed ID: 15094823
    [Abstract] [Full Text] [Related]

  • 18. Characterization of the thiol/disulfide chemistry of neurohypophyseal peptide hormones by high-performance liquid chromatography.
    Yeo PL, Rabenstein DL.
    Anal Chem; 1993 Nov 01; 65(21):3061-6. PubMed ID: 8256869
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Chemical syntheses and biological studies on dimeric chimeras of oxytocin and the V(2)-antagonist, d(CH(2))(5)[D-Ile(2), Ile(4)]arginine vasopressin.
    Chen L, Golser R, Machová A, Slaninová J, Barany G.
    J Med Chem; 1999 Dec 02; 42(24):5002-9. PubMed ID: 10585209
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.